Brant Inman

Professor of Urology

Duke University Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Rachael Thomas

Research Assistant Professor

North Carolina State University

UNITED STATES

View details

Pallavi Avasarala

University of Michigan

UNITED STATES

View details

Ashish Kamat

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Michael Devinney

Duke University

UNITED STATES

View details

Russell K. Pachynski

Washington University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Brant Inman

Research Interests

Explore related searches

Contact this professor

Articles (10)

Whole exome sequencing analysis of canine urothelial carcinomas without BRAF V595E mutation: Short in-frame deletions in BRAF and MAP2K1 suggest alternative mechanisms for MAPK pathway disruption

Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens

A protocol to reduce self-reported pain scores and adverse events following lumbar punctures in older adults

National Quality Improvement Program in Transurethral Resection of Bladder Tumor: A Model for the Rest of Us, Even if We Cannot Share All Results.

En Bloc Resection of Bladder Tumors: Style or Substance?

Partitioning of time trends in prevalence and mortality of bladder cancer in the United States.

Assessments of frailty in bladder cancer.

From Dog's Breakfast to Michelin Guide: Post-bacillus Calmette-Guérin Trials in Non-muscle-invasive Bladder Cancer.

Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.

Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis.

Collaborators (5)

Rachael Thomas

Pallavi Avasarala

Ashish Kamat

Michael Devinney

Russell K. Pachynski

Make your next move.